Articles From: Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers to Hagens Berman Investor Alert: 11 Days Remain before Oct. 21, 2013, Deadline in Velti Securities Class Action


2014/4/1
BRAINTREE, Mass.
Sign-up for Haemonetics Sets Date for Fourth Quarter and Full Fiscal Year 2014 Earnings Release: April 28, 2014 investment picks
2014/2/5
BRAINTREE, Mass.
Sign-up for Haemonetics Sets Date for Investor/Analyst Meeting - May 20, 2014 investment picks
2013/12/20
BRAINTREE, Mass.
Sign-up for Haemonetics Sets Date for Third Quarter Fiscal Year 2014 Earnings Release: January 27, 2014 investment picks
BRAINTREE, Mass.
Sign-up for Haemonetics to Present at the 32nd Annual J.P. Morgan Health Care Conference investment picks
2013/11/13
BRAINTREE, Mass.
Sign-up for Haemonetics to Present at the Jefferies 2013 Global Healthcare Conference investment picks
BRAINTREE, Mass.
Sign-up for Haemonetics to Present at the Morgan Stanley Global Healthcare Conference investment picks
2014/2/13
BRAINTREE, Mass.
Sign-up for Haemonetics to Present at the Raymond James 35th Annual Institutional Investors Conference investment picks
2013/8/12
Hagens Berman Sobol Shapiro LLP (HBSS) has filed a new case on behalf of five alleged victims of multiple German and North American companies, charging that they or their predecessors concealed the distribution of the drug thalidomide to pregnant women in the 1960s, allegedly causing birth defects across the United States.
Sign-up for Hagens Berman Adds Five Cases to Thalidomide Litigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today advised investors of the Oct.
Sign-up for Hagens Berman Advises ECOtality Investors of Upcoming Class-action Deadline and Continuing Investigation investment picks
2013/9/3
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today advised investors of the Oct.
Sign-up for Hagens Berman Advises First Marblehead Corporation Investors of Oct. 28, 2013 Class-action Deadline and Continuing Investigation investment picks
2014/3/31
Hagens Berman Sobol Shapiro LLP, advises investors of InnerWorkings, Inc. (NASDAQ:INWK) (“InnerWorkings”) of the class-action lead plaintiff deadline on April 28, 2014.
Sign-up for Hagens Berman Advises Investors of April 28, 2014, Deadline in InnerWorkings, Inc. Securities Lawsuit and Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the Oct.
Sign-up for Hagens Berman Advises Investors of Deadline in Orthofix Class Action and Continuing Investigation investment picks
2014/3/31
Hagens Berman Sobol Shapiro LLP is investigating MagnaChip Semiconductor Corporation (NYSE: MX) (“MagnaChip”) for securities fraud and advises investors of the class-action lead plaintiff deadline on May 12, 2014.
Sign-up for Hagens Berman Advises Investors of May 12, 2014, Deadline in MagnaChip Semiconductor Corporation Securities Lawsuit and Investigation investment picks
2014/3/31
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Geron Corporation (NASDAQ: GERN) (“Geron” or “the Company”) for securities fraud following allegations that the company distributed false and misleading statements to investors concerning its business and prospects, and advises investors of the class-action lead plaintiff deadline on May 13, 2014.
Sign-up for Hagens Berman Advises Investors of May 13, 2014, Deadline in Geron Corporation Securities Lawsuit and Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Tower Group International, Ltd.
Sign-up for Hagens Berman Advises Investors of Oct. 21, 2013, Deadline in Tower Group International, Ltd. Securities Class-action and Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Velti PLC (NASDAQ: VELT) (“Velti”) for securities fraud following the company’s announcement of a major write-down of receivables in its Greek and Cypriot subsidiaries and advises investors of the class action lead plaintiff deadline on Oct.
Sign-up for Hagens Berman Advises Investors of Oct. 21, 2013, Deadline in Velti PLC Securities Lawsuit and Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today advised investors of the Oct.
Sign-up for Hagens Berman Advises KiOR Investors of Oct. 21, 2013, Class-action Deadline and Continuing Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the Oct.
Sign-up for Hagens Berman Advises KiOR Investors of Oct. 21, 2013, Lead Plaintiff Deadline and Continuing Investigation investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today advised investors of the Oct.
Sign-up for Hagens Berman Advises NuVasive Investors of Oct. 28, 2013, Class-action Deadline and Continuing Investigation investment picks
Hagens Berman today announced that it has been appointed lead counsel in a class-action lawsuit brought against Stericycle (NASDAQ: SRCL) on behalf of small companies who contracted with Stericycle, claiming the hazardous-waste disposal company defrauded them by improperly raising their rates contrary to contract terms.
Sign-up for Hagens Berman Appointed Lead Counsel in Class-Action Lawsuit against Stericycle investment picks
2014/4/4
Hagens Berman, a consumer-rights law firm, is asking employees of Delphi Automotive (NYSE:DLPH) and former employees of General Motors (NYSE:GM) to share information about the 2.6 million vehicles recalled by GM since 2013 for faulty ignition switch issues in the firm’s efforts to uncover other safety issues, and to help protect consumers’ rights though litigation.
Sign-up for Hagens Berman Establishes Tip Line Seeking Information from Former GM and Delphi Employees Regarding Vehicle Recall investment picks
2014/1/28
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm representing investors, wishes to inform purchasers of Nu Skin Enterprises, Inc. (NYSE: NUS) (“Nu Skin” or “the Company”) stock that the Class Period had been extended to cover investments between Oct.
Sign-up for Hagens Berman Informs Investors of Extended Class Period and Deadline to File For Lead Plaintiff in Nu Skin Enterprises Class Action investment picks
2014/1/23
Hagens Berman Sobol Shapiro LLP ("Hagens Berman"), a national investor-rights law firm, today announced it is investigating, on behalf of institutional investors, the terminated merger of Cooper Rubber & Tire Company (“Cooper” or the “Company”) (NYSE: CTB) following the filing of a securities class-action lawsuit claiming the Company and its officers caused significant financial losses to stockholders by withholding risks and misrepresenting information associated with a failed sale to India-based Apollo Tyres Ltd (“Apollo”). Investors or stockholders who suffered significant financial losses related to the case are invited to email CTB@hbsslaw.com for more information.
Sign-up for Hagens Berman Investigates Securities Fraud Claims Over Terminated Cooper Tire Merger on Behalf of Institutional Investors; Announces March 18, 2014 Lead Plaintiff Deadline investment picks
2013/11/25
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today announced it is investigating Tile Shop Holdings, Inc. (“Tile Shop”) (NASDAQ: TTS) following a series of allegations by a short-seller firm, including that the company dramatically overstated earnings and failed to disclose that Beijing Pingxiu, the company’s largest supplier, was secretly controlled by the brother-in-law of Tile Shop’s CEO.
Sign-up for Hagens Berman Investigates Tile Shop Holdings, Inc. investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today announced it is investigating the alleged omission of third-quarter sales trends by Violin Memory Inc. (NYSE:VMEM) (“Violin” or “the Company”) in its SEC filings for its recent IPO.
Sign-up for Hagens Berman Investigates Violin Memory Inc.; Notifies Investors of Jan. 27th Deadline investment picks
2014/3/19
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Galena Biopharma, Inc. (NASDAQ: GALE) (“Galena”) and CytRx Corporation (NASDAQ: CYTR) for securities fraud following an article published on TheStreet.com that claimed the companies used deceptive marketing strategies to inflate stock prices through false and misleading information, and advises investors of the class-action lead plaintiff deadlines of May 5, 2014 and May 13, 2014 for Galena and CytRx cases respectively.
Sign-up for Hagens Berman Investigating Galena Biopharma and CytRx Corporation for Securities Fraud; Notifies Investors of Deadlines investment picks
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors that only 11 days remain before the Oct.
Sign-up for Hagens Berman Investor Alert: 11 Days Remain before Oct. 21, 2013, Deadline in Velti Securities Class Action investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Haemonetics Reports 3rd Quarter Fiscal 2014 Revenue of $242 Million and $0.61 Adjusted EPS; Extends Multi-Year Agreements With Key Plasma Customers to Hagens Berman Investor Alert: 11 Days Remain before Oct. 21, 2013, Deadline in Velti Securities Class Action
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity